Crossref
STM2457 Inhibits Breast Cancer Tumorigenesis via the Inhibition of METTL3
Drug Targets and Therapeutics · 2023
DOI: 10.58502/dtt.23.0015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Targets and Therapeutics, 2023. Verfasst von Pratikshya Shrestha und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shrestha, P., Kang, H., Song, A., Jo, S., Bhattarai, P. Y., & Choi, H. S. (2023). STM2457 Inhibits Breast Cancer Tumorigenesis via the Inhibition of METTL3. Drug Targets and Therapeutics. https://doi.org/10.58502/dtt.23.0015
Vancouver
Shrestha P, Kang H, Song A, Jo S, Bhattarai PY, Choi HS. STM2457 Inhibits Breast Cancer Tumorigenesis via the Inhibition of METTL3. Drug Targets and Therapeutics. 2023. doi:10.58502/dtt.23.0015
BibTeX
@article{Shrestha2023,
author = {Shrestha, Pratikshya and Kang, Hyelim and Song, Ah-yeong and Jo, Sun-young and Bhattarai, Poshan Yugal and Choi, Hong Seok},
title = {STM2457 Inhibits Breast Cancer Tumorigenesis via the Inhibition of METTL3},
journal = {Drug Targets and Therapeutics},
year = {2023},
doi = {10.58502/dtt.23.0015}
}
EUVIMED